Form 4 for ALNY ALNYLAM PHARMACEUTICALS, INC.
Accepted 2022-02-11 00:00:00 ET · period of report 2022-02-09 · accession 0001735276-22-000014 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-11 | 2022-02-09 | ALNY | SHARP PHILLIP A | Dir | M - OptEx | $11.33 | +30.0K | 30.0K | New | +$339.9K |
| D | 2022-02-11 | 2022-02-09 | ALNY | SHARP PHILLIP A | Dir | S - Sale+OE | $150.00 | -30.0K | 0 | -100% | -$4.50M |
| D | 2022-02-11 | 2022-02-09 | ALNY | SHARP PHILLIP A | Dir | M - OptEx | $0.00 | -30.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-09 | M | A | 30,000 | $11.33 | 30,000 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-09 | S | D | 30,000 | $150.00 | 0 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2022-02-09 | M | D | 30,000 | $0.00 | 0 | D | $11.33 · 2013-06-21 to 2022-06-21 | 30,000 Common Stock |